Temasek Holdings, TPG, Prosus, CDPQ, Eight Roads, LGT, Abu Dhabi sovereign wealth fund ADQ, Amansa, OrbiMed and Sunil Kant Munjal’s family office have already committed to invest as much as ₹2,000 crore
Janus Henderson reduced the valuation of its holding in the firm by half which translates into an approximate valuation of $2.8 billion as of December 31, 2022.
PharmEasy is on track for an IPO but is still negotiating with new investors to raise between $200 million and $300 million at a valuation of around $5.6 billion. Talks with SoftBank have reportedly fallen through.